secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0001437749-25-022358
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart delisted from Nasdaq, begins trading on OTCQX after bid price failure
----------------------------------------------------------------------------

- Nasdaq delisted VXRT for non-compliance with minimum bid price requirement (Rule 5550(a)(2)).
- Trading suspended on Nasdaq July 8, 2025; stock began same-day trading on OTCQX Best Market under same ticker.
- Vaxart appealed the delisting on July 3, 2025; shares remain suspended on Nasdaq pending hearing panel decision.
- CEO Steven Lo says focus remains on advancing oral pill vaccine pipeline while considering listing options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774925022358/0001437749-25-022358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774925022358/vxrt20250708_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-022358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer